Literature DB >> 7134846

Fasting serum bile acids in liver disease. A comparison with histological features.

R Alm, J Carlson, S Eriksson.   

Abstract

In a prospective series of 205 patients undergoing liver biopsy, fasting plasma total bile acid (TBA) levels were compared with 11 different histological features. The TBA level was found to correlate positively (P less than 0.001) with the extent of total hepatic damage. In both alcoholic (no. = 93) and non-alcoholic disease (no. = 112) TBA levels correlated better with characteristics consistent with inflammation and Kupffer cell activity than with connective tissue changes. The degree of steatosis had no effect on TBA levels. Of 117 patients with greater than or equal to 5 of 33 possible biopsy score points, 44, or 38%, had normal TBA levels. All patients with biopsy scores greater than or equal to 12 had abnormally high TBA. Although an elevated fasting TBA level is specific for hepatobiliary disease, the test is insensitive and is not appropriate for screening purposes. This applies equally to alcoholic and non-alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134846     DOI: 10.3109/00365528209182042

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Highlights From the AASLD/EASL ALD Endpoints Conference 2019.

Authors:  Madeline Bertha; Haripriya Maddur
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

2.  Bile Acids in Hepatic Encephalopathy.

Authors:  Sharon DeMorrow
Journal:  J Clin Exp Hepatol       Date:  2018-05-04

3.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

4.  Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.

Authors:  T A Robb; G P Davidson; C Kirubakaran
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

5.  Endogenous bile acid tolerance test for liver function.

Authors:  M van Blankenstein; M Frenkel; J W van den Berg; F J ten Kate; E P Bosman-Jacobs; A C Touw-Blommesteyn
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

Review 6.  The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-07       Impact factor: 46.802

Review 7.  Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting.

Authors:  Matias A Avila; Jean-François Dufour; Alexander L Gerbes; Fabien Zoulim; Ramon Bataller; Patrizia Burra; Helena Cortez-Pinto; Bin Gao; Ian Gilmore; Philippe Mathurin; Christophe Moreno; Vladimir Poznyak; Bernd Schnabl; Gyongyi Szabo; Maja Thiele; Mark R Thursz
Journal:  Gut       Date:  2019-12-26       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.